CRH Medical posted revenues of $28.73 million for the third quarter of 2018, fueled by a $6.8 million increase in anesthesia service growth.
GI & Endoscopy
Takeda's ulcerative colitis drug Entyvio was one of the key products behind a 4.2 percent increase in underlying revenue.
Researchers examined the effectiveness of transoral incisionless fundoplication in controlling symptoms associated with chronic refractory gastroesophageal reflux disease, according to a poster presented at ACG 2018, Oct. 5-10 in Philadelphia.
Gerard Isenberg, MD, is a gastroenterologist at Cleveland-based University Hospitals.
Here are four updates on gastroenterology companies from the past week:
Advertisement
Fight Colorectal Cancer awarded a research grant to Christine Sardo Molmenti, PhD, and Heather Hampel to advance research on early-onset colorectal cancer.
Exact Sciences posted $118.3 million in third quarter 2018 revenue, a 63 percent year-over-year increase.
The Colon Cancer Coalition's stolen inflatable colon was found Monday outside a vacant house, the Star Tribune reported.
Jamison, Pa.-based Physicians Endoscopy finalized partnerships with three gastroenterology ASCs, bringing its portfolio to a total of 60 centers and 600-plus gastroenterologist partners.
A study published in Current Opinions Gastroenterology examined the recent research on adverse effects attributed to proton pump inhibitors, Medscape reports.